Accurate in directionAccuracy in direction. I started with penny stocks then forex. Through it all I stuck with reading the charts and understanding it. I've used tradeview as a diary for myself.
0%
0%
0%
0%
0%
About Citius Pharmaceuticals, Inc
Sector
Health Technology
Industry
Medical Specialties
CEO
Leonard L. Mazur
Website
citiuspharma.com
Headquarters
Cranford
Employees
21
Founded
2007
ISIN
US17322U2078
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.
CTXR 2M Long Termtest
Citius Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary produ
This company hits all the right spots! Hi there, Yurii Domaranskyi here.
Risk vs Reward = 1 to 23.63 ✨
It means if you risk here 100$ you may make 2363$ Not bad, huh?
Citius Pharmaceuticals Announces FDA Acceptance of IND ApplicatiCTXR: Citius Pharmaceuticals, Inc.
2022-02-15 09:15:00
Citius Pharmaceuticals Announces FDA Acceptance of IND Application for its Phase 2b Study of Halo-Lido for the Prescription Treatment of Hemorrhoids
My current portfolio, don't hate on meI think these companies have a lot to give.
What do you think?
CTXR ready to jumpBased on volume price movements,I expect CTXR will go up
Take Profit: 2.6
Stop Loss: 1.97
CTXR 15Min Scalper's editiontest
Citius Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary produ
CTXR Overall Very Bullish- CTXR very bullish long term / current trend has been UP and will continue
- higher lows / higher highs
- MACD Green
- Bullish Divergence on the RSI
- I expect CTXR to have a retrace to 2.34 and finally bottom at 1.54 the .618 Fib for the perfect entry
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
